June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Non-invasive electric stimulation suppresses microglia activation and laser-induced choroidal neovascularization
Author Affiliations & Notes
  • Anton Lennikov
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Medical Biochemistry, Oslo Universitetssykehus, Oslo, Norway
  • Menglu Yang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Daisy Y Shu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Zhengping Hu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Karen Chang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Medical Biochemistry, Oslo Universitetssykehus, Oslo, Norway
  • Wai Lydia Tai
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Julie Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Boyuan Li
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Li PAN
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Optometry, The Hong Kong Polytechnic University, Hong Kong, Hong Kong
  • Ajay Ashok
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Medical Biochemistry, Oslo Universitetssykehus, Oslo, Norway
  • Cherin Lee
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Christina Yen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Kin-Sang Cho
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Tor Paaske Utheim
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Medical Biochemistry, Oslo Universitetssykehus, Oslo, Norway
  • Dongfeng Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Anton Lennikov Schepens Eye Research Institute, Code P (Patent); Menglu Yang None; Daisy Shu None; Zhengping Hu None; Karen Chang Schepens Eye Research Institute, Code P (Patent); Wai Lydia Tai None; Julie Chen None; Boyuan Li None; Li PAN None; Ajay Ashok None; Cherin Lee None; Christina Yen None; Kin-Sang Cho Firecyte Therapeutics, Code C (Consultant/Contractor), Schepens Eye Research Institute, Code P (Patent); Tor Utheim Schepens Eye Research Institute, Code P (Patent); Dongfeng Chen FireCyte Therapeutics, Code C (Consultant/Contractor), i-Lumen Scientific , Code C (Consultant/Contractor), Sichuan PriMed, Code C (Consultant/Contractor), Schepens Eye Research Institute, Code P (Patent)
  • Footnotes
    Support  The Norwegian Research Council; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway (T.P.U); Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway (T.P.U); The Norwegian Association for the Blind and Partially Sighted (T.P.U); The Ministry of Science and Technology of Taiwan MOST 105-2917-I-002-031, MOST 109-2917-I-564-032 (K.C.); BrightFocus Foundation (K.S.C.); National Eye Institute Grant EY031696 (D.F.C); Harvard NeuroDiscovery Center Grant (D.F.C); Core Grant for Vision Research from NIH/NEI to the Schepens Eye Research Institute (P30EY003790).
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1295. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anton Lennikov, Menglu Yang, Daisy Y Shu, Zhengping Hu, Karen Chang, Wai Lydia Tai, Julie Chen, Boyuan Li, Li PAN, Ajay Ashok, Cherin Lee, Christina Yen, Kin-Sang Cho, Tor Paaske Utheim, Dongfeng Chen; Non-invasive electric stimulation suppresses microglia activation and laser-induced choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1295.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age-related macular degeneration (AMD) manifests with microglia activation and abnormal blood vessel growth leading to rapid loss of central vision. Electrical stimulation (ES) employing a low-intensity current presents a potential therapeutic modality that can be applied non-invasively to the skin of the eyelid. In this study, we investigated the effects of ES on laser CNV in vivo and microglial activation and endothelial cell (EC) tube formation in vitro.

Methods : Laser CNV was induced in adult C57BL/6 mice with a 532-nm laser (150 mW, spot size: 50 μm, pulse: 50 ms). The mice were then subjected to the daily ES (biphasic ramp, 300 µA, 20 Hz, transpalpebral, 4 min) or sham treatment. In vivo evaluations were recorded 7 days post-laser CNV using fluorescein angiography (FA), optic coherence tomography (OCT), and immunolabeling of retinal pigment epithelia/choroidal/scleral complexes (RCSC). In vitro primary microglia and primary human retinal endothelial cells (HREC) were subjected to ES (biphasic, 300 µA, 20 Hz, 1 h). Calcium flux in response to ATP (10-7 M) stimulation (120 sec) was measured by Fura-2. HREC angiogenic potential was evaluated by tube formation and choroidal explant assays. HREC expression of VEGFa was detected by western blotting.

Results : ES in vivo reduced FA leakage area (p<0.01) and the size of the laser CNV lessons measured by OCT (p<0.01) compared to sham-treated mice (Fig 1). RCSC immunolabeling indicated significant reductions of lectin-positive area (P<0.01), the number of infiltrating IBA-1 (p<0.05) and COX-2 positive cells (p<0.05), and VEGFa signal (p<0.05). ES in vitro reduced ATP-induced Ca2+ flux in cultured microglia (p<0.05) and HREC cells (p<0.01). Results of seahorse analysis indicated reduced basal (p<0.05) and maximum (p<0.05) respiration and ATP production (p<0.01) in microglia The tube formation (p<0.01), choroidal explants outgrowth (p<0.05), and VEGF expression (p<0.01) were suppressed by the ES application in vitro.

Conclusions : ES inhibits microglia activation and EC angiogenic responses by reversibly depolarising mitochondrial potential and ATP production, reducing Ca2+ flux in response to proinflammatory and pro-angiogenic stimuli. The ES is a promising non-invasive therapeutic strategy for ocular inflammation and angiogenesis.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Fig 1. Therapeutic transpalbabral ES attenuates laser-induced choroidal neovascularization in mice.

Fig 1. Therapeutic transpalbabral ES attenuates laser-induced choroidal neovascularization in mice.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×